CARSO Group has acquired a majority stake in AQCF Group
CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.
Founded in 1992 and hearquartered in France, CARSO Group is one of the leading providers of analytical services in the French market, with activities in neighboring countries. The wide range of analysis offered includes water and environment testing, occupational hygiene and building health, food, genetics and pharma analysis. In 2021, ARCHIMED became CARSO Group’s majority shareholder, in partnership with CAPZA, Siparex, the management team and the founders. Since becoming the majority shareholder, ARCHIMED has supported the company’s organic and external growth across Europe, through mergers and partnerships in the most attractive market segments. The common objective is to strengthen CARSO’s position as an independent, entrepreneurial and international platform in the world of analytical services.
Founded in 2007 and COFRAC-accredited, AQCF Group provides all players in the agri-food sector with its skills and know-how in quality, safety and environmental management, offering a wide range of analysis for food and water quality control, consultancy services in food hygiene and safety, consultancy services in laboratory layout and restructuring, and customized training.
Oaklins’ team in France advised CARSO Group and its shareholders on the acquisition of AQCF Group.
Talk to the deal team
Related deals
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreGroupe JVS has completed an LBO with Capza and Bpifrance
The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn more